Both Intec Pharma Ltd. (NASDAQ:NTEC) and Tiziana Life Sciences PLC (NASDAQ:TLSA) compete on a level playing field in the Biotechnology industry. We will evaluate their performance with regards to institutional ownership, profitability, risk, analyst recommendations, dividends, earnings and valuation.
In table 1 we can see Intec Pharma Ltd. and Tiziana Life Sciences PLC’s gross revenue, earnings per share and valuation.
Table 2 represents Intec Pharma Ltd. (NASDAQ:NTEC) and Tiziana Life Sciences PLC (NASDAQ:TLSA)’s return on equity, return on assets and net margins.
Insider and Institutional Ownership
The shares of both Intec Pharma Ltd. and Tiziana Life Sciences PLC are owned by institutional investors at 39.64% and 0.28% respectively. Insiders held roughly 11.81% of Intec Pharma Ltd.’s shares.
In this table we show the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.